Alumis Stock
HealthTechLooking to sell Alumis Stock or Options? Get a free valuation
Founded: 2021Funding to Date: $638M
Visit websiteAlumis is a developer of precision medicines designed to address autoimmune diseases. The company's analytics platform and in-depth knowledge of immunologic diseases assist in the creation of treatments and medicines for such conditions. This enables patients to alleviate their suffering and transform their lifestyle.
Investors Include:
Nextech Invest, HBM Healthcare Investments, Foresite Capital, venBio, Omega Funds, SR One Capital Management, Cormorant Asset Management, Piper Sandler, Matrix Capital Management, Foresite Labs, Ally Bridge Group, NexTech, Lilly Asia Ventures, Samsara BioCapital.